FL-ONERAIL
On the heels of record growth, OneRail completes a $33 million Series B funding round, co-led by Piva Capital and Arsenal Growth Equity. Shippers continue to re-evaluate last mile logistics with a more strategic eye, based on a multitude of factors, including providing a superior shipper-branded customer experience, increased dependability and delivery speed, and cost containment, while meeting sustainability objectives. Supply chain transformation has become a catalyst for competitive advantage for shippers of all types and OneRail replaces siloed legacy systems and manual processes (Excel, VRS, TMS, etc.) to leverage a virtuous cycle of transportation performance data — driving measurable improvements in affordability, dependability, speed and sustainability for its customers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221130005117/en/
Bill Catania and Lisa Catania (Photo: Business Wire)
OneRail’s comprehensive last mile solution is anchored by its delivery operating system, which automates last mile logistics, intelligently selecting the right shipping mode and courier or carrier network to optimize every order. OneRail’s delivery fulfillment platform is directly connected to an unparalleled real-time connected network of nearly 10 million drivers, which is supported by its Exceptions Assist™ operations layer — a USA-based exceptions management team available 24/7 who actively get ahead of delivery issues before they occur. With an on-time delivery rate of more than 98 percent, OneRail has firmly established itself as the go-to provider for an expanding range of industries, including retailers, healthcare networks, wholesale product distributors, and construction and materials distributors alike.
“Since our Series A round in 2021, we’ve grown revenue year-over-year by 312 percent and have expanded service to over 330 U.S. cities,” said OneRail CEO and founder Bill Catania. “As the connective tissue between our customers, courier networks and consumers, our delivery fulfillment system is currently transacting over 12 million data calls per minute, producing a mountain of data which is further unlocked through this growth round of funding, helping our customers achieve greater efficiencies, new fulfillment capabilities and corporate sustainability objectives.”
OneRail will leverage this funding round to develop a multitude of new data-driven platform capabilities focused on improving the dependability, affordability, and sustainability of last mile logistics. In addition to the development of new capabilities, OneRail also intends to greatly expand its sales, marketing, and solution engineering teams to meet increased shipper demand for more efficient last mile solutions.
“OneRail is in a pivotal position to help solve last mile issues that plague companies and consumers,” said Adzmel Adznan, co-founding partner with Piva Capital. “As shifts in consumer behavior become more demanding, there is a need for dependable, affordable and sustainable fulfillment solutions, especially in the underserved segment of B2B and industrial deliveries. OneRail’s market understanding and execution is second to none — we are delighted to partner with the team, and look forward to seeing what’s next.”
One such B2B supply chain customer is American Tire Distributors (ATD). “OneRail has enabled ATD to provide our tire retailers across the U.S. with additional last mile delivery services to meet their consumers’ needs,” said Stuart Schuette, president & CEO of ATD. “As their first enterprise customer, we have enjoyed working with the OneRail team to evolve and grow their service offerings together. We are excited to continue solving the ever-changing demand and last mile delivery solutions that meet the needs of the replacement tire and automotive aftermarket industries.”
The funding builds on a successful 2022 that saw OneRail’s platform deployed from over 10,000 unique shipper locations, debut at #48 on this year’s Inc. 5000 list, and named to the FreightTech 100 for the second year in a row. OneRail’s Logistics Partner Network, a managed marketplace that seamlessly benefits shippers and courier businesses, grew by four million, up 66 percent year over year. With nearly 100 team members based in Orlando, Fla., OneRail caught the eye of Arsenal Growth Equity, also based in Orlando.
“OneRail’s growth over the past 24 months is validation of their differentiated supply chain solution for the last mile,” stated Arsenal Growth Equity Founding Partner John Trbovich. “Having invested throughout the e-commerce ecosystem, in companies such as Cart.com and Orderbot, we believe OneRail’s robust technology platform, coupled with our confidence in its team, vision and strategy, will transform the last mile logistics sector.”
Signifying the strength and confidence in OneRail’s solution, additional investors include Trimble Ventures, the corporate capital venture fund of Trimble, a global leader in construction, agriculture and transportation technologies; ATD; as well as existing investors Ironspring Ventures, Las Olas Venture Capital, Bullpen Capital, Triphammer Ventures/Alumni Ventures Group, Gaingels and Mana Ventures. The latest investment brings the company’s total funding efforts to $54.5 since announcing its Seed Round two years ago.
About OneRail
OneRail is an Orlando-based last mile transportation visibility solution providing shippers with Amazon-level dependability and speed. With a real-time connected network of 10 million drivers, OneRail finds the right vehicle for the right delivery, so shippers gain low prices and greater capacity to rapidly scale their businesses. Across retail, CPG, distribution, construction, healthcare and more, OneRail offers an exceptional last mile delivery experience with an on-time delivery rate of 98.6%, while keeping brands front and center. To learn more about OneRail, visit OneRail.com.
About Piva Capital
Piva Capital is a San Francisco-based venture capital firm investing in visionary entrepreneurs who are solving the world's critical industrial challenges with breakthrough technologies and innovative business models. For more information, visit Piva.vc, or the company’s LinkedIn and Medium profiles.
About Arsenal Growth Equity
Arsenal Growth Equity is an execution-stage private equity firm based in Florida. Founded in 1999, Arsenal invests in emerging software companies across a myriad of sectors — targeting capital efficient, high-growth businesses where they can leverage their operational and strategic network to help founders scale. For more information, visit www.arsenalgrowth.com.
About American Tire Distributors
American Tire Distributors is one of the largest independent suppliers of tires to the replacement tire market. It operates more than 115 distribution centers, serving approximately 80,000 customers across the U.S. The company offers an unsurpassed breadth and depth of inventory, frequent delivery and value-added services to tire and automotive service customers. American Tire Distributors employs approximately 4,500 associates across its distribution center network. In 2022, the company was recognized as one of Forbes’ 2022 America’s Best Midsize Employers, America’s Top 100 Most Loved Workplaces by Newsweek and one of Charlotte’s Best and Brightest Companies to Work For® by the National Association for Business Resources.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005117/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom